APEA- Endocrine Pharm Exam Questions with Correct Answers
Question 1:
Aspart (NovoLog) should be administered:
10 minutes prior to a meal. 30 minutes prior to a meal. 30 minutes after a meal. just before
sleep. approximately:
5 minutes.
15 minutes.
Answer:
10 minutes prior to a meal
Maximum plasma concentrations of glucagon, after intramuscular injection, are observed in 30
minutes.
Question 2:
45 minutes.
Answer:
15 minutes.
The maximum plasma concentration of glucagon, after intramuscular administration to a
patient with
Question 3:
Patients who are receiving radioiodine therapy for hyperthyroidism should be advised to: avoid
contact with young children for several days.
avoid becoming pregnant during treatment and for 12 months after treatment.
Answer:
severe hypoglycemia, are obtained in approximately 13 minutes expect hair loss over the next 3
months.
Question 4:
monitor for laryngeal damage.
Answer:
avoid contact with young children for several days.
Patients who receive radioiodine have the potential to expose their home and household
contacts via saliva and urine due to radiation emitting from their body. Patients must take
radiation precautions for
,Question 5:
Because of the mechanism of action, patients should be instructed to administer exenatide
(Byetta): daily at bedtime.
immediately following the largest meal of the day.
Answer:
several days after treatment, avoiding contact with young children and pregnant women.
Question 6:
at least 12 hours apart, regardless of meals.
Answer:
twice daily, within 1 hour prior to morning and evening
Question 7:
Patients should be instructed to administer exenatide (Byetta) within 60 minutes prior to the
morning
Answer:
meals.
and evening meal (or prior to the 2 main meals of the day). Injections should be administered
Question 8:
When patients administer regular insulin (Humulin R U-500), they should be taught: 5 units of
Humulin R U-500 is equal to 10 units on a U-100 insulin syringe.
10 units of Humulin R U-500 is equal to 5 units on a U-100 insulin syringe.
Answer:
approximately =6 hours apart
10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe.
Question 9:
it should only be used in an insulin pump.
Answer:
10 units of Humulin R U-500 is equal to 10 units on a U-500
Question 10:
For safety, ONLY the U-500 syringe should be used. It is not recommended for use in insulin
pumps due
Answer:
insulin syringe.
, Question 11:
The combination of metformin (Glucophage) and glyburide (Diabeta) for the treatment of Type
2 diabetes is:
moderately efficacious with low risk of hypoglycemia. moderately efficacious with high risk of
hypoglycemia.
Answer:
to possibility of precipitation.
highly efficacious with moderate risk of hypoglycemia.
Question 12:
highly efficacious with low risk of hypoglycemia.
Answer:
highly efficacious with moderate risk of
Question 13:
Because the effect of these 2 medications in combination is additive, together they can
potentially
Answer:
hypoglycemia.
Question 14:
Insulin glargine (Lantus) is NOT indicated in the treatment of: adults with Type 1 diabetes
mellitus.
adults with Type 2 diabetes mellitus.
Answer:
decrease A1C 2-4%. This is considered highly efficacious. pediatric patients with Type 1 diabetes
mellitus.
Question 15:
pediatric patients with Type 2 diabetes mellitus.
Answer:
pediatric patients with Type 2 diabetes mellitus.
Question 16:
Insulin detemir (Levemir):
has a longer duration of action than insulin glargine (Lantus). may be used in insulin pumps.
Answer:
The FDA has not approved Lantus for use in children with Type 2 diabetes. may be administered
once or twice daily.
Question 1:
Aspart (NovoLog) should be administered:
10 minutes prior to a meal. 30 minutes prior to a meal. 30 minutes after a meal. just before
sleep. approximately:
5 minutes.
15 minutes.
Answer:
10 minutes prior to a meal
Maximum plasma concentrations of glucagon, after intramuscular injection, are observed in 30
minutes.
Question 2:
45 minutes.
Answer:
15 minutes.
The maximum plasma concentration of glucagon, after intramuscular administration to a
patient with
Question 3:
Patients who are receiving radioiodine therapy for hyperthyroidism should be advised to: avoid
contact with young children for several days.
avoid becoming pregnant during treatment and for 12 months after treatment.
Answer:
severe hypoglycemia, are obtained in approximately 13 minutes expect hair loss over the next 3
months.
Question 4:
monitor for laryngeal damage.
Answer:
avoid contact with young children for several days.
Patients who receive radioiodine have the potential to expose their home and household
contacts via saliva and urine due to radiation emitting from their body. Patients must take
radiation precautions for
,Question 5:
Because of the mechanism of action, patients should be instructed to administer exenatide
(Byetta): daily at bedtime.
immediately following the largest meal of the day.
Answer:
several days after treatment, avoiding contact with young children and pregnant women.
Question 6:
at least 12 hours apart, regardless of meals.
Answer:
twice daily, within 1 hour prior to morning and evening
Question 7:
Patients should be instructed to administer exenatide (Byetta) within 60 minutes prior to the
morning
Answer:
meals.
and evening meal (or prior to the 2 main meals of the day). Injections should be administered
Question 8:
When patients administer regular insulin (Humulin R U-500), they should be taught: 5 units of
Humulin R U-500 is equal to 10 units on a U-100 insulin syringe.
10 units of Humulin R U-500 is equal to 5 units on a U-100 insulin syringe.
Answer:
approximately =6 hours apart
10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe.
Question 9:
it should only be used in an insulin pump.
Answer:
10 units of Humulin R U-500 is equal to 10 units on a U-500
Question 10:
For safety, ONLY the U-500 syringe should be used. It is not recommended for use in insulin
pumps due
Answer:
insulin syringe.
, Question 11:
The combination of metformin (Glucophage) and glyburide (Diabeta) for the treatment of Type
2 diabetes is:
moderately efficacious with low risk of hypoglycemia. moderately efficacious with high risk of
hypoglycemia.
Answer:
to possibility of precipitation.
highly efficacious with moderate risk of hypoglycemia.
Question 12:
highly efficacious with low risk of hypoglycemia.
Answer:
highly efficacious with moderate risk of
Question 13:
Because the effect of these 2 medications in combination is additive, together they can
potentially
Answer:
hypoglycemia.
Question 14:
Insulin glargine (Lantus) is NOT indicated in the treatment of: adults with Type 1 diabetes
mellitus.
adults with Type 2 diabetes mellitus.
Answer:
decrease A1C 2-4%. This is considered highly efficacious. pediatric patients with Type 1 diabetes
mellitus.
Question 15:
pediatric patients with Type 2 diabetes mellitus.
Answer:
pediatric patients with Type 2 diabetes mellitus.
Question 16:
Insulin detemir (Levemir):
has a longer duration of action than insulin glargine (Lantus). may be used in insulin pumps.
Answer:
The FDA has not approved Lantus for use in children with Type 2 diabetes. may be administered
once or twice daily.
